Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Net Cash Flow: 2017-2024

Historic Net Cash Flow for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to -$1.5 million.

  • DiaMedica Therapeutics' Net Cash Flow fell 106.64% to -$858,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$12.9 million, marking a year-over-year decrease of 183.65%. This contributed to the annual value of -$1.5 million for FY2024, which is 733.51% down from last year.
  • DiaMedica Therapeutics' Net Cash Flow amounted to -$1.5 million in FY2024, which was down 733.51% from -$185,000 recorded in FY2023.
  • Over the past 5 years, DiaMedica Therapeutics' Net Cash Flow peaked at $3.5 million during FY2020, and registered a low of -$2.7 million during FY2021.
  • For the 3-year period, DiaMedica Therapeutics' Net Cash Flow averaged around -$568,667, with its median value being -$185,000 (2023).
  • In the last 5 years, DiaMedica Therapeutics' Net Cash Flow skyrocketed by 127.25% in 2020 and then tumbled by 980.95% in 2023.
  • Yearly analysis of 5 years shows DiaMedica Therapeutics' Net Cash Flow stood at $3.5 million in 2020, then slumped by 176.63% to -$2.7 million in 2021, then surged by 100.78% to $21,000 in 2022, then slumped by 980.95% to -$185,000 in 2023, then crashed by 733.51% to -$1.5 million in 2024.